别嘌呤醇
非布索坦
医学
黄嘌呤氧化酶
冲程(发动机)
黄嘌呤氧化酶抑制剂
痛风
阿司匹林
尿酸
内科学
改良兰金量表
不利影响
高尿酸血症
安慰剂
药理学
病理
缺血性中风
生物化学
机械工程
化学
替代医学
缺血
工程类
酶
作者
Sara R. Britnell,Kelly A Chillari,Jamie N. Brown
出处
期刊:Current Vascular Pharmacology
[Bentham Science]
日期:2018-09-10
卷期号:16 (6): 583-588
被引量:8
标识
DOI:10.2174/1570161115666170919183657
摘要
Background: Xanthine oxidase inhibitors are commonly used to lower uric acid levels in patients with gout. Due to their effects on endothelial function, they have also been investigated for possible benefits for patients with cardiovascular disease. Objective: To assess the efficacy and safety of xanthine oxidase inhibitors in the treatment of patients with history of stroke. Methods: MEDLINE (1946-June 2017) and EMBASE (1947-June 2017) were queried using the search terms: “allopurinol” OR “febuxostat” OR “xanthine oxidase inhibitor” OR “xanthine oxidase/ antagonists and inhibitors” AND “stroke” OR “cerebral infarction” OR “cerebrovascular accident”. Studies appropriate to the objective were evaluated, including five randomized, placebo-controlled, double-blind trials investigating the effect of allopurinol in patients with history of stroke. No articles evaluating the use of febuxostat in this setting were identified. Results: In patients with history of stroke, treatment with allopurinol resulted in improvements in several markers of endothelial function, inflammatory markers, and scores on the Modified Rankin Scale. Study durations ranged from 6 weeks to 1 year, and studies used varying doses of allopurinol. Allopurinol was well tolerated in most studies, with some reports of gastrointestinal adverse effects, headache and rash. Conclusion: Based on the reviewed literature, allopurinol appears to be a promising therapy to improve vascular function and reduce disability in patients who have had a stroke. The benefits seen are in combination with current standard of care treatments with aspirin and lipid-lowering therapy. Larger trials are necessary to better understand the role of allopurinol in patients with history of stroke. Keywords: Allopurinol, stroke, cerebrovascular disease, vascular endothelium, febuxostat, secondary prevention, uric acid.
科研通智能强力驱动
Strongly Powered by AbleSci AI